Estrogen Receptors Differentially Regulates Intracellular Calcium Handling in Human Non-asthmatic and Asthmatic Airway Smooth Muscle Cells.
Asthma is defined as chronic inflammation of the airways and is characterized by airway remodeling, hyperresponsiveness and acute bronchoconstriction of airway smooth muscle (ASM) cells. Clinical findings suggest a higher incidence asthma in adult women, indicating a role of sex steroids in modulating the airway tone. Estrogen, a major female sex steroid mediates its role through estrogen receptors (ER), ERα and ERβ which are shown to be expressed in human ASM and their expression is upregulated in inflammation/asthma. Previous studies suggested rapid, non-genomic signaling of estrogen via ERs reduces intracellular Calcium([Ca2+]i). However, long-term ER activation on [Ca2+]i regulation in human ASM during asthma is still not known. In Fura-2 loaded non-asthmatic and asthmatic human ASM cells, we found that prolonged (24h) exposure to ERα agonist (PPT) increased [Ca2+]i response to histamine, whereas ERβ activation (WAY) led to decreased [Ca2+]compared to vehicle. This was further confirmed by ER overexpression and knockdown studies using various bronchoconstrictor agents. Interestingly, ERβ activation was more effective than 17β-estradiol in reducing [Ca2+]i responses in presence of TNFα or IL-13, while no observable changes were noticed with PPT in the presence of either cytokine. The [Ca2+]i reducing effects of ERβ were mediated partially via L-type calcium channel inhibition and increased Ca2+ sequestration by sarcoplasmic reticulum. Overall, these data highlight the differential signaling of ERα and ERβ in ASM during inflammation. Specific ERβ activation reduces [Ca2+]i in the inflamed ASM cells and is likely to play a crucial role in regulating ASM contractility thereby relaxing airways.